SWOT Analysis for Zoecon, and the Product, ROACH ENDER Essay -- essays

SWOT analytic thinking for Zoecon, and the Product, rotary ENDER Main Problem AnalysisWhile no real problem exists with Zoecon, there is a strife of interests in regard to how consider band ENDER is marketed. A meeting was engraft in which Zoecon executives were to analyze and discuss the test market results for the bash ROACH ENDER, after it was placed in a consumer test market for hexad months in four cities representative of the 19-city market where 80 percent of lap insecticides were sold. These four cities included Charleston, South Carolina Beaumont, Texas Charlotte, North Carolina and New Orleans, Louisiana. After these sise months, executives were to determine which option would benefit Zoecon, resulting in the greatest return on profit. After analyzing the results, executives came up with three different options in which to market Strike ROACH ENDER. These options includedOption One was to expand the Strike ROACH ENDER distribution to the 19 cities where Strike FLE A ENDER was being sold. The research conducted by Zoecons mysterious marketing research group showed that the 19 cities accounted for 80 percent of round insecticide volume. The executives at Zoecon agreed that the primary direct costs associated with distributing Strike ROACH ENDER to these 19 cities would be a price of $1,016,000. This cost would silver screen the advertising and promotions for the purpose of creating brand awareness in these 19 cities. The executives similarly agreed that the set-up/auditing, marketing research, and miscellaneous costs would not be perennial in order to expand distribution. Option Two Executives believed that Zoecon should focus on directing their resources to Pest Control Operators, (PCOs). They noted that GENCOR (hydropene) had been greatly received by PCOs in 1984. At the end of this year, many PCOs were promoting GENCORs benefits to their customers. These Zoecon executives agreed that with an annual investment funds of $500,000 every yea r above the 27 percent of sales would be enough for trade advertising and and sales efforts towards accelerating use. Option Three Zoecon executives suggested that they take after opportunities for selling hydropene to the makers of d-Con, Black Flag, and Raid for use in their products. While this dodging had worked in the past for PRECOR (methopene), it could pose as a menace or possible... ... above their competition. WeaknessesWhile there isnt a great deal of weaknesses to this option, executives exponent still agree that our competition will take advantage of our prospect for growth in the consumer market. While this may be true, the results could be overmuch worse if Zoecon jumps into the consumer market before gaining the reputation and earnings they would have produced from head start with the PCOs support behind their product. Zoecon has a specially designed product that is O.K. by strong, scientific research. Even though Zoecons competitors will have a few years to breathe freely, after developing widespread vigilance from professionals, and gaining competitive edge, Zoecon is bound to quickly surprise the consumer market in the future.ThreatsThe only if potential threats to this option is new innovations, or a lack of timing. Zoecons patents will eventually time out, which will give competition access to the controlled compounds that Zoecon formulated. Although this threat could potentially destroy Zoecons existence, the chances of this happening are very slim to some impossible unless every one of their plans fail in the PCO market.